SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Citigroup Maintains Buy on Reata Pharmaceuticals, Raises Price Target to $328

Citigroup maintains Reata Pharmaceuticals (NASDAQ:RETA) with a Buy and raises the price target from $241 to $328.

Benzinga · -

Citigroup maintains Reata Pharmaceuticals (NASDAQ:RETA) with a Buy and raises the price target from $241 to $328.